期刊文献+

生长抑素对人球后成纤维细胞增殖的影响 被引量:1

The Influence of Somatostatin 14 on the Proliferation of Human Retroocular Fibroblasts
下载PDF
导出
摘要 目的 探讨生长抑素 1 4 (SS1 4 )治疗 Graves眼病的机理 ,为临床应用提供实验依据。方法 培养人球后成纤维细胞 (hum an retro- ocular fibroblast,HROFb) ,用 MTT比色法测定细胞增殖状况 ,并观察 SS1 4 对HROFb的生长、增殖的影响。结果 所测光吸收值与成纤维细胞的数目呈正相关 (r=0 .996,P<0 .0 0 1)。SS1 4 在低浓度下 (<0 .2 5 nmol/ L)可促进 HROFb 增殖 ,当浓度 >2 5 nm ol/ L 时则可抑制 HROFb的增殖 ,且具剂量效应关系。HROFb的增殖率与 SS1 4 浓度呈负相关 (r=- 0 .90 5 4,P<0 .0 0 1)。结论 生长抑素对人成纤维细胞增殖有双相作用。 Objective To elucidate the possible mechanism of Somatostatin 14 in the treatment of Graves' ophthalmopathy, thus providing laboratory data with the intent to underpin therapeutic developments. Methods The human retro ocular fibroblasts (HROFb) was cultured and MTT colorimetry assay was used to determine the proliferation of HROFb. Results MTT colorimetry assay could precisely reflect the proliferation of HROFb. The absorbance was directly proportional to the numbers of the cells ( r=0.996,P <0.001). Somatostatin 14 could enhance the cell proliferation percentage at lower levels (<25nmol/L) and inhibit that at higher levels (>25nmol/L). The cell proliferation correlated positively to Somatostatin 14 levels significantly ( r=-0.9054, P <0.001). Conclusion Somatostatin 14 has a dual effect on HROFb.
出处 《华西医科大学学报》 CSCD 北大核心 2001年第3期399-401,共3页 Journal of West China University of Medical Sciences
关键词 GRAVES眼病 成纤维细胞 MTT比色法 生长抑素14 Graves' ophthalmopathy MTT colorimetry assay Somatostatin 14 Fibroblast
  • 相关文献

参考文献5

二级参考文献2

共引文献3

同被引文献12

  • 1黄勤,张家庆.Octreotide对人眼球后和皮肤成纤维细胞DNA合成的影响[J].第二军医大学学报,1995,16(6):572-572. 被引量:2
  • 2KAZIM M, GOLDBERG RA, SMITH TJ. Insights into the pathogenesis of thyroid-associated orbitopathy[J].Arch Ophthalmol, 2002,120(3) : 380-386.
  • 3陈灏珠.实用内科学[M].上册.第10版.北京:人民卫生出版社,1998:1024-1026.
  • 4PASQUALI D, VASSALLO P, ESPOSITO D,et al. Somatostatin recptors gene expression and inhibitory effects of oetreotide on primary cultures of orbital fibroblasts from Graves' ophthalmopathy[J]. J mol Endocrinol, 2000,25 : 63-71.
  • 5KRASSAS GE, PONTIKIDES N, KALTSAS, et al. Free and total insulin-like growth factor(IGF)-I, II, and IGF binding protein-1 ,- 2,and-3 serum levels in patients with active thyroid eye disease [J]. J Clin Endoerinol Metab,2003,88(1):132-135.
  • 6JONES JI, CI.EMMONS DR. Insulin-like growth factors and their binding proteins : biological actions[J]. Endocr Rev, 1995,16 (1) : 3-34.
  • 7KLISOVIC DD, SALL JW, O'DORISIO MS,et al. Somatostatin (SST) and octreotide (OCT) inhibit IGF-1 mediated tyrosine autophosphorylation o( IGF-1Rbeta and induction of VEGF gene expression in human RPE cells[J]. Invest Ophtbalmol Vis Sci,2001, 42,S244.
  • 8李志杰.Graves眼病的免疫学[J].眼科新进展,2001,21(5):309-312. 被引量:11
  • 9王宇泓.IGF-I的免疫调节作用[J].国外医学(免疫学分册),2001,24(4):187-189. 被引量:2
  • 10顾明君,刘志民,朱莉,沈玉美,石勇铨,徐洁.奥曲肽和泼尼松治疗甲状腺相关性眼病的随机对照研究[J].第二军医大学学报,2002,23(5):540-543. 被引量:15

引证文献1

二级引证文献4

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部